Evaxion A (EVAX) Tax Provisions (2020 - 2026)
Evaxion A (EVAX) posted Tax Provisions of $216000.0 for Q1 2026, down 15.29% quarter-over-quarter from $255000.0 in Q4 2025, and up 12.5% year-on-year from $192000.0 in Q1 2025.
Evaxion A (EVAX) Tax Provisions (2020 - 2026) Analysis & Trends
Evaxion A (EVAX) has reported Tax Provisions for 7 consecutive years, with $216000.0 the latest figure, recorded in Q1 2026.
- Tax Provisions for Q1 2026 came in at $216000.0, up 12.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $931000.0 (up 22.18% YoY), and the FY2025 annual result was $908000.0, up 15.23% from the prior year.
- Tax Provisions was $216000.0 for Q1 2026 at Evaxion A, down from $255000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $275000.0 in Q4 2024 and troughed at $96000.0 in Q3 2024.
- Average Tax Provisions over 5 years is $204294.1, with a median of $195000.0 recorded in 2025.
- Year-over-year, Tax Provisions slumped 73.54% in 2022 and soared 176.04% in 2025.
- Over 5 years, Tax Provisions stood at $173000.0 in 2022, then climbed by 2.31% to $177000.0 in 2023, then soared by 55.37% to $275000.0 in 2024, then decreased by 7.27% to $255000.0 in 2025, then dropped by 15.29% to $216000.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $216000.0 in Q1 2026, $255000.0 in Q4 2025, and $265000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | - |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -859,000.00 |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 31.86 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 221.50 Mn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | -459,000.00 |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 60.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 15.66 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | - |
| 10 | Evaxion A | 1.33 Bn | 1.33 Bn | - | 216,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | 265,000.00 |
| Jun 30, 2025 | 195,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 199,000.00 |
| Mar 31, 2024 | 218,000.00 |
| Dec 31, 2023 | 177,000.00 |
| Sep 30, 2023 | 194,000.00 |
| Jun 30, 2023 | 225,000.00 |
| Mar 31, 2023 | 194,000.00 |
| Dec 31, 2022 | 173,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 177,000.00 |
| Mar 31, 2022 | 247,000.00 |
| Dec 31, 2021 | -1.32 Mn |
| Sep 30, 2021 | 425,000.00 |
| Jun 30, 2021 | 669,000.00 |